Colon Cancer Clinical Trials

A listing of Colon Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

UPDATED

Tucson Arizona 85719

A clinical research study of CPI-444 and CPI-444 + atezolizumab

California

UPDATED

San Francisco California 94143

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Long Beach California 90806

Patients are needed to participate in a clinical research study for the treatment of Colon Cancer

Los Angeles California 90095

Patients are needed to participate in a clinical research study evaluating MGA271 plus Ipilimumab for the treatment of Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer

San Diego California 92121

A clinical trial seeking patients for a research study for the treatment of Colon Cancer, Colon Adenomas or Colon Polyps

Santa Monica California 90404

A clinical trial seeking patients for a research study for the treatment of Metastatic Colorectal Cancer, Colon Cancer or Rectal Cancer

Colorado

UPDATED

Aurora Colorado 80045

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Aurora Colorado 80045

A clinical trial seeking patients for a research study for the treatment of Metastatic Colorectal Cancer, Colon Cancer or Rectal Cancer

Connecticut

New Haven Connecticut

Patients are needed to participate in a clinical research study evaluating MGA271 plus Ipilimumab for the treatment of Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer

Delaware

Newark Delaware 19713

A clinical trial seeking patients for a research study for the treatment of Metastatic Colorectal Cancer, Colon Cancer or Rectal Cancer

District of Columbia

Washington District of Columbia 20007

Patients are needed to participate in a clinical research study for the treatment of Colon Cancer

Washington District of Columbia 20007

Patients are needed to participate in a clinical research study of Regorafenib to evaluate Colon Cancer

Florida

Additional Locations Florida

Patients are needed to participate in a clinical research study of Regorafenib to evaluate Colorectal Neoplasms, Adenocarcinoma of the Colon or Adenocarcinoma of the Rectum

Gainesville Florida 32610

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Georgia

Memorial University Medical Center
Savannah Georgia 31404

CALGB 80702: A Phase III trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer.

View More ▼

UPDATED

Atlanta Georgia 30322

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Illinois

Sherman Health
Elgin Illinois 60123

NSABP P-5 Phase III Randomized Study of Adjuvant Rosuvastatin in Patients With Resected Stage I or II Colon Cancer

View More ▼

UPDATED

Chicago Illinois 60637

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Decatur Illinois 62526

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Indiana

UPDATED

Indianapolis Indiana 46202

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Goshen Indiana 46526

A clinical trial seeking patients for a research study for the treatment of Metastatic Colorectal Cancer, Colon Cancer or Rectal Cancer

South Bend Indiana 46628

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Iowa

Davenport Iowa 52804

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Iowa City Iowa 52242

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Waterloo Iowa 50702

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Maine

Scarborough Maine 04074

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Maryland

UPDATED

Baltimore Maryland 21287

A clinical research study of CPI-444 and CPI-444 + atezolizumab

UPDATED

Baltimore Maryland 21201

Patients are needed to participate in a clinical research study of MGA271 and Pembrolizumab to evaluate Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer, Refractory Cancer

Baltimore Maryland 21205

A clinical trial to evaluate treatments using MGD007 for patients with Colorectal Carcinoma

Massachusetts

Boston Massachusetts 02114

A clinical trial to evaluate treatments using MGD007 for patients with Colorectal Carcinoma

Boston Massachusetts 02215

A clinical trial to evaluate treatments using MGD007 for patients with Colorectal Carcinoma

Pittsfield Massachusetts 01201

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Michigan

UPDATED

Detroit Michigan 48201

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Lansing Michigan 48910

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Missouri

UPDATED

St. Louis Missouri 63110

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Nebraska

Omaha Nebraska 68106

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Nevada

Las Vegas Nevada 89106

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

New Jersey

Long Branch New Jersey 07740-6395

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Newark New Jersey 07112

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Toms River New Jersey 08755

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

New York

The Rockefeller University Hospital
New York New York 10065

Identification of autoantibodies targeting genes implicated in metastatic cancer

View More ▼

UPDATED

New York New York 10065

A clinical research study of CPI-444 and CPI-444 + atezolizumab

UPDATED

New York New York 10029

A clinical research study of CPI-444 and CPI-444 + atezolizumab

UPDATED

New York New York 10032

A clinical research study of CPI-444 and CPI-444 + atezolizumab

UPDATED

New York New York 10032

Patients are needed to participate in a clinical research study of MGA271 and Pembrolizumab to evaluate Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer, Refractory Cancer

Bronx New York 10461

A clinical research study of Oxaliplatin for the treatment of Colon Cancer or Rectal Cancer

Bronx New York 10467

A clinical research study of Oxaliplatin for the treatment of Colon Cancer or Rectal Cancer

Bronx New York 10469

Patients are needed to participate in a clinical research study evaluating CPI-613 for the treatment of Advanced Solid Tumor Cancer or Metastatic Solid Tumor Cancer

New York New York 10029

A clinical trial seeking patients for a research study for the treatment of Colon Cancer, Rectal Cancer or Colorectal Cancer

New York New York 10032

Patients are needed to participate in a clinical research study evaluating MGA271 plus Ipilimumab for the treatment of Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer